Ra Medical Systems Inc. (NYSEMKT:RMED)

There are currently no videos for this stock.
To request coverage of this stock, please click the green request video box on the right.
Bands Volume 200 SMA 50 SMA 20 SMA Videos Alerts Articles Events
RMED Weekly Chart

Old Forum Content for RMED

Make a Forum Post
Become a member to view recent forum posts. Already a member? Sign in here.
  • Orange-Green: seeing some strength in $RMED.. looks like a monster weekly C&H formation
  • geotheo: #IPOs- IPOs expected to price: Vioma Technology ($VIOT) on September 24; Capital Bancorp ($CBNK), Entasis Therapeutics ($ETTX), SVMK ($SVMK), Arco Platform ($ARCE) and CooTek Cayman ($CTK) on September 25; Sutro Biopharma ($STRO), RA Medical Systems ($RMED), LAIX ($LAIX), Urovant Sciences ($UROV) and Arvinas ($ARVN) on September 26; Gristone Oncology ($GRTS) on September 27 IPO lockup expirations: GreenTree Hospitality (NYSE:$GHG), OP Bancorp (NASDAQ:$OPBK), Homology Medicines (NASDAQ:$FIXX), Bilibili (NASDAQ:$BILI) and OneSmart Internet Education (NYSE:$ONE) on September 24; Iqiyi (NASDAQ:$IQ) Unum Therapeutics (NASDAQ:$UMRX) and Genprex (NASDAQ:$GNPX) on September 25.
Visit the Trading Forum to join in the discussion.
Stock Price $USD 3.27
Change -0.30%
Volume 489,154

Ra Medical Systems Inc is a commercial-stage medical device company leveraging its laser-based platform for use in the treatment of vascular and dermatological immune-mediated inflammatory diseases. Its products restore blood-flow in arteries and clearing chronic skin conditions. The firm's products include DABRA and Pharos. DABRA System is used as a tool in the treatment of peripheral artery disease, or PAD, a form of peripheral vascular disease, which commonly occurs in the legs. Pharos is designed for use in the treatment of inflammatory skin conditions and as a tool in the treatment of psoriasis, vitiligo, atopic dermatitis, and leukoderma. It operates in two segments, the Vascular segment and the Dermatology segment, of which key revenue is derived from the Dermatology segment.

Request Video of RMED
Already a member? Sign in here.


  • August 10th, 2021 - 2021 Q2 Earnings
Past Month

Leading Peers

Past Month

Lagging Peers

Dan Fitzpatrick

Stock Market Mentor gives you EVERYTHING you need to succeed in the market; all in one place. How easy is that? Dan Fitzpatrick and his elite community of traders share trading ideas, strategies and much more. Dan Fitzpatrick--a world class Technical Analyst, trading coach and regular CNBC contributor--gives you access to all of this with a 30 day trial membership for just $7.77. Get started TODAY and start trading better TOMORROW with the following premium content:

  • Nightly video Strategy Sessions with a game plan for tomorrow
  • Got a stock you want Dan to look at? Just ask.
  • Patent pending video alerts instantly delivered to you when one of Dan’s trading signals is triggered. This is not your typical price alert. This is a short video explaining the action you need to take to make money. No more “Woulda, coulda, shoulda”
  • Access to over 82,200 stock analysis videos
  • Access an ever expanding library (82,200) of educational videos that will save you time and make you money

Join a team of friends and traders that have one thing in common; a burning desire to succeed.

Become a Member Today!

Gain immediate access to all our exclusive articles, features, how-to's, discussion group and much more...

Satisfaction Guaranteed!

Your Stock Market Mentor membership comes with a 30 day, no questions asked, 100% money back guarantee!